Clinical Trials Browser

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Phase 2 Completed

34 enrolled 22 charts

Sarcoma

Sarcoma, Alveolar Soft Part

NCT00712712 2025-08-29

MEDOR

Phase 2 Completed

78 enrolled 28 charts

Neoplasm Metastasis, Pain

NCT04165096 2025-06-25

MK-3475-01C

Phase 2 Completed

128 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT03084536 2024-12-24

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Phase 2 Completed

134 enrolled 9 charts

Breast

Breast Neoplasms

NCT04660799 2023-10-12

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Phase 2 Completed

50 enrolled 25 charts

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02839668 2019-10-29

TIVA/TCI-BC

Phase 2 Completed

120 enrolled

Breast

Breast Neoplasms

NCT03111186 2019-09-26

Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery

Phase 2 Completed

40 enrolled

Carpal Tunnel Syndrome, Dupuytren Contracture, Ganglion Cysts, Trigger Finger Disorder, De Quervain Disease

NCT01985126 2018-06-25

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Phase 2 Completed

124 enrolled 18 charts

Plasma cell

Multiple Myeloma

NCT00899847 2017-10-20

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Phase 2 Completed

9 enrolled 15 charts

Plasma cell

Multiple Myeloma

NCT02252926 2016-08-16

Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

Phase 2 Completed

70 enrolled

Other

Mucositis

NCT00003346 2013-06-25

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Completed

80 enrolled

Dermatologic

Melanoma

Clinical Trials

KETOCOL

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

MEDOR

MK-3475-01C

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

TIVA/TCI-BC

Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma